Thank you to everyone who attended our joint reception tonight with Global Alzheimer's Platform Foundation, CEOi - Global CEO Initiative on Alzheimer's Disease, and UsAgainstAlzheimer's at #AAIC24. We are so grateful for the contributions of our partners and their work towards ending Alzheimer’s everywhere.
Davos Alzheimer's Collaborative’s Post
More Relevant Posts
-
https://lnkd.in/ddHb8npm We will be attending the Alzheimer's Association® International Conference (AAIC) in Philadelphia from July 28th to August 1st! We'll have Brittany Weddington, Director of Business Development; Dani Cabral, MD, Principal Investigator of our Phoenix site; Mireya Medina, Site Director of our Albuquerque site there to discuss the latest research and learn more about our work in Alzheimer's disease. Set up a meeting today! #AAIC2024 #AlzheimersResearch #DementiaResearch #ClinicalTrials #AlzheimersandBrainAwarenessMonth
To view or add a comment, sign in
-
-
That's a wrap for our Lunch&Learn series 2023! In this final webinar, we delved into Alzheimer's Disease, discussing its multifaceted aspects and the different diagnostic methods available. We would like to thank everyone who joined us and we look forward to having you again. #webinar #alzheimersdisease #lunchandlearn
To view or add a comment, sign in
-
-
🌅 The Longest Day: Standing Together Against Alzheimer's 🌅 Today, on the summer solstice, we join thousands around the world in observing #TheLongestDay, a day dedicated to fighting Alzheimer's disease. This powerful event, organized by the Alzheimer's Association®, symbolizes the challenging journey faced by those living with Alzheimer's and their caregivers. At SYNAPS Dx - an Alzheimer's Diagnostic company, we are deeply committed to advancing the understanding, diagnosis, and treatment of Alzheimer's disease. Our team works tirelessly to diagnose patients and provide answers to patients and their families, offering hope and clarity in the face of this relentless condition. On this longest day of the year, let's stand together to honor the strength, heart, and endurance of those affected by Alzheimer's. Whether you're participating in an event, sharing your story, or simply spreading awareness, every action counts. Let's shed light on the darkness of Alzheimer's and work towards a future where this disease is a thing of the past. Together, we can make a difference. 💜 #TheLongestDay #EndAlz #AlzheimersAwareness #SYNAPSDx #DISCERNtest #AlzheimersDiagnostics
To view or add a comment, sign in
-
-
We were delighted to introduce InRAD, an international, practice-based registry for Alzheimer's Disease and other dementias at the EADC (European Alzheimer's Disease Consortium) annual meeting yesterday. One of our founding Board members, Frank Jessen, explained how InRAD can help address pressing questions about the clinical management of Alzheimer's disease, enable large study collaborations with a common minimum data set and facilitate a wide range of sub-studies on a global scale. Click here to find out more about InRAD and join our effort to accelerate progress in Alzheimer's practice-based research: https://lnkd.in/gGDTvs6i #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry
To view or add a comment, sign in
-
-
As you return to work and cleanout your inboxes to start 2024, considering adding a really meaningful message to your week by signing up for our E-Newsletter below
Stay connected to the Greater PA Chapter by signing up for our weekly e-news! Learn about upcoming programs and events, resources for families navigating an Alzheimer's diagnosis and ways to get involved and inspired. Visit alz.org/enews to start receiving weekly updates!
To view or add a comment, sign in
-
-
Payers should be prepared for the wave of patients coming and open up resources to keep them aging in place with a caregiver at home. This is where I’d like to see more innovation and learning. The Alzheimers initiative for payers is a great use case for machine learning and prediction using data made accessible via Patent Access API for operational use cases to inform future management of the Alzheimers wave predicted to spike in 2025 (reported by CNN nearly 5 years ago). The time has come, payers and providers should be prepared and properly reimbursed for serving these vulnerable populations. These patents are excluded from Quality measurement, but the financial burden of not following this population will be huge if organizations don’t get ahead of it now.
Molina Healthcare is a proud supporter of the 2024 Unforgettable Tour, which is presented by the Alzheimer’s Association to raise awareness about Alzheimer’s and other forms of dementia in underserved communities. The goal of the production is to draw more attention to the benefits of early diagnosis and treatment for a disease that affects nearly 7 million Americans, with a disproportionate impact on communities of color. Learn more: https://bit.ly/3AqLQ5S
To view or add a comment, sign in
-
-
New therapies today drive the eradication/attenuation of disease tomorrow 💪 Here at Alcyomics, we feel privelleged to help make this happen 😌🔬 🔈Speak to us today about how our models and assays, including Skimune, can provide research solutions for you! #therapies #immunotoxicology
Parkinson's Awareness Month, celebrated every April, is dedicated to increasing awareness about Parkinson's Disease, supporting those affected, and fundraising for research. This April, let's unite to amplify understanding, support those impacted, and fuel research progress. Skimune® offers advanced safety testing to all innovative new therapies so let's take a moment to appreciate how the work we are doing today will influence the therapies of tomorrow. Join us by contributing to a future where Parkinson's is a memory. Together, we can make a difference. To find out more about how Skimune® can support your safety and efficacy testing visit the Alcyomics website or reach out directly to info@alcyomics.com. #parkinsonsuk #worldparkinsonsday
To view or add a comment, sign in
-
-
Registries are powerful tools for conducting observational studies of disease with impact on public health surveillance, research, and intervention, and inform and engage policymakers. Frank Jessen, one of our founding Board members, shared at the EADC (European Alzheimer's Disease Consortium) annual meeting how InRAD may impact clinical management, foster large-scale collaborations, and enable global studies. Join us in accelerating Alzheimer's research! https://lnkd.in/gGDTvs6i #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry
We were delighted to introduce InRAD, an international, practice-based registry for Alzheimer's Disease and other dementias at the EADC (European Alzheimer's Disease Consortium) annual meeting yesterday. One of our founding Board members, Frank Jessen, explained how InRAD can help address pressing questions about the clinical management of Alzheimer's disease, enable large study collaborations with a common minimum data set and facilitate a wide range of sub-studies on a global scale. Click here to find out more about InRAD and join our effort to accelerate progress in Alzheimer's practice-based research: https://lnkd.in/gGDTvs6i #InRAD #AlzheimersResearch #GlobalImpact #EADC #RealWorldData #AlzheimersRegistry
To view or add a comment, sign in
-
-
💜 November marks Alzheimer's Awareness Month, a time to unite in support of those battling this challenging disease. At AriBio, we're committed to raising awareness, amplifying research efforts, and standing by all those affected. Together, we're driving change towards a future without Alzheimer's. 💜 #alzheimers #alzheimersdisease #alzheimersresearch #alzheimersawarenessmonth #alzheimersawareness
To view or add a comment, sign in
-
-
Senior at TMSA interested in Neuro-tech & AI | Stanford Harris ‘25 | Duke CeBA '24 | Duke DUNE '23 |
Learn more about what our Alzheimer's Foundation of America chapter is doing through our website. Here, you'll find out what we do, our impact in numbers, our blog publications, and most importantly how to get involved!
To view or add a comment, sign in
Clinical Evidence | Product & Portfolio Strategy
1moIt was a great event!